Order Entry
Austria
ContactUsLinkComponent
Human recombinant LILRA1 (from HEK293)
Human recombinant LILRA1 (from HEK293)
Supplier:  ACRO Biosystems
Certificates
Human recombinant LILRA1 (from HEK293)
Supplier:  ACRO Biosystems

Specifications

  • Protein/Peptid-Typ:
    Rekombinant
  • Ursprung:
    HEK293 cells
  • Spezies:
    Human
  • Lagerbedingungen:
    –20 °C
  • Endotoxingehalt:
    Less than 1,0 EU per μg by the LAL method.
  • Biologische Aktivität:
    Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4. Normally trehalose is added as protectant before Lyophilisation.; Measured by its binding ability in a functional ELISA. Immobilised Human ANGPTL7, His Tag (Cat. No. AN7-H52H5) at 5 μg/ml(100 μl/well) can bind Biotinylated Human LILRA1, His,Avitag (Cat. No. LI1-H82E8) with a linear range of 0.313-2.5 μg/ml(QC tested).
  • Gen-ID:
    O75019-1
  • Frei von Trägern:
    Y
  • Frei von Proteasen:
    Y
  • Tierfrei:
    Y
  • Proteinsynonym:
    LILRA1|LIR6|LIR-6|CD85i
  • Protein/Peptid-Name:
    LILRA1
  • Purity:
    >90%
  • Molecular weight:
    52,2 kDa
  • Endotoxinspiegel:
    Low
  • Zusammensetzung:
    Lyophilised from 0,22 μm filtered solution in PBS, pH 7,4, Normally trehalose is added as protectant before Lyophilisation.
  • Frei von Nukleasen:
    Y
  • Transporttemperatur:
    Powder,RT

Specifications

Frequently Bought Together